Regression curves of brain metastases after gamma knife irradiation: Difference by tumor and patient characteristics

Cancer Science

Volumn 103, Issue 11, 2012, Pages 1967-1973

  Kosaki, Katsura ^a   Shibamoto, Yuta ^a   Hirai, Tatsuo ^b   Hatano, Manabu ^b   Tomita, Natsuo ^a   Kobayashi, Tatsuya ^c   Mori, Yoshimasa ^c  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Heisei Memorial Hospital   (Japan)

^c Nagoya Radiosurgery Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BREAST ADENOCARCINOMA; CANCER PATIENT; CANCER REGRESSION; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GAMMA KNIFE RADIOSURGERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HEMOGLOBINS; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSPECTIVE STUDIES; RADIOSURGERY; REGRESSION ANALYSIS;

EID: 84868158518     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02392.x     Document Type: Article

References (35)

1. Barlliot I, Horriot JC, Pigneux J et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostic factors. Int J Radiat Oncol Biol Phys 1997; 38: 969-78.
2. Yalman D, Aras AB, Ozkök S et al. Prognostic factors in definitive radiotherapy of uterine cervical cancer. Eur J Gynaecol Oncol 2003; 24: 309-14.
3. Munzenrider JE. Recent advances in radiotherapy. Rev Interam Radiol 1977; 2: 123-33.
4. Milsom I, Friberg LG. Primary adenocarcinoma of the uterine cervix. A clinical study. Cancer 1983; 52: 942-7.
5. Guichard M, Weichselbaum RR, Little JB, Malaise EP. Potentially lethal damage repair as a possible determinant of human tumour radiosensitivity. Radiother Oncol 1984; 1: 263-9.
6. Shibamoto Y, Yukawa Y, Tsutsui K, Takahashi M, Abe M. Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sites. Jpn J Cancer Res 1986; 77: 908-15.
7. Stanley JA, Shipley WU, Steel GG. Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour. Br J Cancer 1977; 36: 105-13.
8. Overgaard J, Hansen HS, Andersen AP et al. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. Int J Radiat Oncol Biol Phys 1989; 16: 1065-8.
9. Grogan M, Thomas GM, Melamed I et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999; 86: 1528-36.
10. Henke M, Sindlinger F, Ikenberg H, Gerds T, Schumacher M. Blood hemoglobin level and treatment outcome of early breast cancer. Strahlenther Onkol 2004; 180: 45-51.
11. Hoff CM, Hansen HS, Overgaard M et al. The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy - Results from the randomized DAHANCA 5 study. Radiother Oncol 2011; 98: 23-33.
12. Mortensen LS, Busk M, Nordmark M et al. Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study. Radiother Oncol 2011; 99: 418-23.
13. Shibamoto Y, Sugie C, Iwata H. Radiotherapy for metastatic brain tumors. Int J Clin Oncol 2009; 14: 281-8.
14. Rahn DA III, Ray DK, Schlesinger DJ et al. Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment? Cancer 2011; 117: 414-20.
15. Mori Y, Kobayashi T, Shibamoto Y. Stereotactic radiosurgery for metastatic tumors in the pituitary gland and the cavernous sinus. J Neurosurg 2006; 105(Suppl): 37-42.
16. Serizawa T, Hirai T, Nagano O et al. Gamma knife surgery for 1-10 brain metastases without prophylactic whole-brain radiation therapy: analysis of cases meeting the Japanese prospective multi-institute study (JLGK0901) inclusion criteria. J Neurooncol 2010; 98: 163-7.
17. Motulsky H. Appropriate sample size. In: Motulsky H ed.; Tsuzaki K, trans. Intuitive Biostatics. Tokyo: Science Medical, 1997; 196-205.
18. Nagai A, Shibamoto Y, Mori Y et al. Increases in the number of brain metastases detected at frame-fixed, thin-slice MRI for gamma knife surgery planning. Neuro Oncol 2010; 12: 1187-92.
19. Kim SK, Kondziolka D, Flickinger JC et al. Stereotactic radiosurgery for patients with non-small cell lung carcinoma metastatic to brain. Cancer 1997; 80: 2075-83.
20. Serizawa T, Ono J, Iichi T et al. Gamma knife radiosurgery for metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma. J Neurosurg 2002; 97 (Suppl 5): 484-8.
21. Ohta Y, Oda M, Tsunezuka Y et al. Results of recent therapy for non-small cell lung cancer with brain metastasis as the initial relapse. Am J Clin Oncol 2002; 25: 476-9.
22. Pan HC, Sheehan J, Stroila M, Steiner M, Steiner L. Gamma knife surgery for brain metastases from lung cancer. J Neurosurg (Suppl) 2005; 102: 128-33.
23. Nakagawa K, Tago M, Terahara A et al. A single institutional outcome analysis of Gamma Knife radiosurgery for single or multiple brain metastases. Clin Neurol Neurosurg 2000; 102: 227-32.
24. Ohmori T, Podack ER, Nishio K et al. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. Biochem Biophy Res Commun 1993; 192: 30-6.
25. Watanabe H, Kanamori I, Ohno K et al. Tumor biology. In: Watanabe H, Kanamori I, eds. Introduction to Radiotherapy, 2nd edn (in Japanese). Tokyo: Iryo Kagaku Sha; 2008: 1-30.
26. Tsukahara Y, Sakai Y, Noguchi H, Iwai S, Fukuta T. A study on radiosensitivity and prognostic factors of cervical adenocarcinoma. Acta Obst Gynaec Jpn 1980; 32: 1609-14.
27. Perez CA, Stanley K, Rubin P et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Cancer 1980; 45: 2744-53.
28. Shibamoto Y, Hashizume C, Baba F et al. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study. Cancer 2012; 118: 2078-84.
29. Shibamoto Y, Shibata T, Miyatake S et al. Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus assay. Br J Cancer 1994; 70: 67-71.
30. West CM, Davidson SE, Burt PA, Hunter RD. The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data. Int J Radiat Oncol Biol Phys 1995; 31: 841-6.
31. Shibamoto Y, Ike O, Mizuno H et al. Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome. Clin Cancer Res 1998; 4: 677-82.
32. Hasegawa T, Kondziolka D, Flickinger JC et al. Stereotactic radiosurgery for brain metastases from gastrointestinal tract cancer. Surg Neurol 2003; 60: 506-15.
33. Takeda A, Kunieda E, Ohashi T et al. Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer. Radiother Oncol 2011; 101: 255-9.
34. Iwata H, Murai T, Shibamoto Y. Radiation response of the normal lung tissue and lung tumors. In: Jeremic B ed. Advances in Radiation Oncology in Lung Cancer, 2nd edn. Berlin, Heidelberg: Springer-Verlag, 2011: 119-28.
35. Varlotte J, Stevenson MA. Anemia, tumor hypoxemia, and the cancer patient. Int J Radiat Oncol Biol Phys 2005; 63: 25-36.